VITRANO, Angela
VITRANO, Angela
Scienze Economiche, Aziendali e Statistiche
Chelation treatment in sickle-cell-anaemia: much ado about nothing?
2011-01-01 Lucania, G; Vitrano, A; Filosa, A; Maggio, A
Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yields of CD34+ Cells with Primitive Signatures
2015-01-01 Elena Baiamonte; Barone, R.; Stefano, R.; Iacono, M.; Spina, B.; Contino, F.; Maggio, R.; Sacco, M.; Vitrano, A.; Feo, S.; Maggio, A.; Acuto, A.
Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience
2010-01-01 Restivo Pantalone, G; Renda, D; Valenza, F; D'Amato, F; Vitrano, A; Cassarà, F; Rigano, P; Di Salvo, V; Giangreco, A; Bevacqua, E; Maggio, A
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
2009-01-01 Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Magnano, C; Rizzo, M; Caruso, V; Gerardi, C; Argento, C; Campisi, S; Cantella, F; Commendadore, F; D’Ascola, DG; Fidone, C; Ciancio, A; Galati, MC; Giuffrida, G; Cingari, R; Giugno, G; Lombardo, T; Prossomariti, L; Malizia, R; Meo, A; Roccamo, G; Romeo, MA; Violi, P; Cianciulli, P; Rigano, P
Iron Chelation Therapy in thalassaemia major: a sistematic review with meta-analyses of 1520 patients included on randomized clinical trials
2011-01-01 Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; Cianciulli, P; Grady, RW; Prossomariti, L; Porter, JB; Iacono, A; Cappellini, MD; Bonifazi, F; Cassarà, F; Harmatz, P; Wood, J; Gluud, C
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassemia major patients: a randomised clinical trial
2009-01-01 Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Romeo, MA; Magnano, C; Caruso, V; Argento, C; Gerardi, C; Campisi, S; Violi, P; Malizia, R; Cianciulli, P; Rizzo, M; D’Ascola, DG; Quota, A; Prossomariti, L; Fidone, C; Rigano, P; Pepe, A; D’Amico, G; Morabito, A; Gluud, C
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major
2013-01-01 Filosa, A; Vitrano, A; Rigano, P; Calvaruso, G; Barone, R; Capra, M; Cuccia, L; Gagliardotto, F;Pitrolo, L; Prossomariti, L; Casale, M; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Rizzo, M; D'Ascola, G; Ciancio, A; Maggio, A
Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients
2012-01-01 Maggio, A; Vitrano, A; Lucania, G; Capra, M; Cuccia, L; Gagliardotto, F; Pitrolo, L; Prossomariti, L; Filosa,A; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Rizzo, M; D’Ascola, G; Ciancio, A; Di Maggio, R; Calvaruso, G; Pantalone, GR; Rigano, P
Modelling Spatio-Temporal Elephant Movement Data: a Generalized Additive Mixed Models Framework
2014-03-28 Vitrano, .
Nonsense-mediated decay mechanism is a possible modifying factor of clinical outcome in nonsense cd39 beta thalassemia genotype
2012-01-01 Renda, MC; Vitrano, A; Attanasio, M; Fecarotta, E; Piazza, A; Giambona, A; Fiorentino, G; Renda, D; Rigano, P; Calvaruso, G; Cassarà, F; Maggio, A
Reliability of EMA Binding Test in Diagnosis of Hereditary Spherocytosis in Italian Patients
2011-01-01 D'Alcamo, E; Agrigento, V; Sclafani, S; Vitrano, A; Cuccia, L; Maggio, A; Perrotta, S; Capra, M; Rigano, P
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in thalassemia major patients
2011-01-01 Pantalone, GR; Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Romeo, MA; Magnano, C; Caruso, V; Argento, C; Gerardi, C; Campisi, S; Violi, P; Malizia, R; Cianciulli, P; Rizzo, M; D'Ascola, DG; Quota, A; Prossomariti, L; Fidone, C; Rigano, P; Pepe, A; D'Amico, G; Morabito, A; Gluud, C
Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death
2013-01-01 Maggio, A; Vitrano, A; Calvaruso, G; Barone, R; Rigano, P; Mancuso, L; Cuccia, L; Capra, M; Pitrolo, L; Prossomariti, L; Filosa, A; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Elefteriou, A; Angastiniotis, M; Hamzac, H; Telfer, P; Walkerc, JM; Phrommintikul, A; Chattipakorn, N
The Challenge of Using CB-HSCs As Source for Gene Therapy: Lentiviral Vector Transduction, Phenotypic Characterization and Global Gene Expression Profile of Ex-Vivo Expanded CB CD34+ Cells
2015-01-01 Rosalia Di Stefano*, 1.; Baiamonte, E.; Iacono, M.; Spina, B.; Contino, F.; Coronnello, C.; Sacco, M.; Maggio, R.; Vitrano, A.; Feo, S.; Maggio, A.; Acuto, A.
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-gen-2011 | Chelation treatment in sickle-cell-anaemia: much ado about nothing? | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Lucania, G; Vitrano, A; Filosa, A; Maggio, A | |
| 1-gen-2015 | Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yields of CD34+ Cells with Primitive Signatures | BARONE, RitaCONTINO, FlaviaVITRANO, AngelaFEO, Salvatore + | 01 - Contributo in rivista::1.13 Abstract in rivista | Elena Baiamonte; Barone, R.; Stefano, R.; Iacono, M.; Spina, B.; Contino, F.; Maggio, R.; Sacco, M.; Vitrano, A.; Feo, S.; Maggio, A.; Acuto, A. | |
| 1-gen-2010 | Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Restivo Pantalone, G; Renda, D; Valenza, F; D'Amato, F; Vitrano, A; Cassarà, F; Rigano, P; Di Salvo, V; Giangreco, A; Bevacqua, E; Maggio, A | |
| 1-gen-2009 | Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Magnano, C; Rizzo, M; Caruso, V; Gerardi, C; Argento, C; Campisi, S; Cantella, F; Commendadore, F; D’Ascola, DG; Fidone, C; Ciancio, A; Galati, MC; Giuffrida, G; Cingari, R; Giugno, G; Lombardo, T; Prossomariti, L; Malizia, R; Meo, A; Roccamo, G; Romeo, MA; Violi, P; Cianciulli, P; Rigano, P | |
| 1-gen-2011 | Iron Chelation Therapy in thalassaemia major: a sistematic review with meta-analyses of 1520 patients included on randomized clinical trials | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Maggio, A; Filosa, A; Vitrano, A; Aloj, G; Kattamis, A; Ceci, A; Fucharoen, S; Cianciulli, P; Grady, RW; Prossomariti, L; Porter, JB; Iacono, A; Cappellini, MD; Bonifazi, F; Cassarà, F; Harmatz, P; Wood, J; Gluud, C | |
| 1-gen-2009 | Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassemia major patients: a randomised clinical trial | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Romeo, MA; Magnano, C; Caruso, V; Argento, C; Gerardi, C; Campisi, S; Violi, P; Malizia, R; Cianciulli, P; Rizzo, M; D’Ascola, DG; Quota, A; Prossomariti, L; Fidone, C; Rigano, P; Pepe, A; D’Amico, G; Morabito, A; Gluud, C | |
| 1-gen-2013 | Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Filosa, A; Vitrano, A; Rigano, P; Calvaruso, G; Barone, R; Capra, M; Cuccia, L; Gagliardotto, F;Pitrolo, L; Prossomariti, L; Casale, M; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Rizzo, M; D'Ascola, G; Ciancio, A; Maggio, A | |
| 1-gen-2012 | Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Maggio, A; Vitrano, A; Lucania, G; Capra, M; Cuccia, L; Gagliardotto, F; Pitrolo, L; Prossomariti, L; Filosa,A; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Rizzo, M; D’Ascola, G; Ciancio, A; Di Maggio, R; Calvaruso, G; Pantalone, GR; Rigano, P | |
| 28-mar-2014 | Modelling Spatio-Temporal Elephant Movement Data: a Generalized Additive Mixed Models Framework | VITRANO, Angela | 04 - Tesi di dottorato::4.2 Tesi di dottorato | Vitrano, . | |
| 1-gen-2012 | Nonsense-mediated decay mechanism is a possible modifying factor of clinical outcome in nonsense cd39 beta thalassemia genotype | VITRANO, AngelaATTANASIO, Massimo + | 01 - Contributo in rivista::1.01 Articolo in rivista | Renda, MC; Vitrano, A; Attanasio, M; Fecarotta, E; Piazza, A; Giambona, A; Fiorentino, G; Renda, D; Rigano, P; Calvaruso, G; Cassarà, F; Maggio, A | |
| 1-gen-2011 | Reliability of EMA Binding Test in Diagnosis of Hereditary Spherocytosis in Italian Patients | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | D'Alcamo, E; Agrigento, V; Sclafani, S; Vitrano, A; Cuccia, L; Maggio, A; Perrotta, S; Capra, M; Rigano, P | |
| 1-gen-2011 | Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in thalassemia major patients | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Pantalone, GR; Maggio, A; Vitrano, A; Capra, M; Cuccia, L; Gagliardotto, F; Filosa, A; Romeo, MA; Magnano, C; Caruso, V; Argento, C; Gerardi, C; Campisi, S; Violi, P; Malizia, R; Cianciulli, P; Rizzo, M; D'Ascola, DG; Quota, A; Prossomariti, L; Fidone, C; Rigano, P; Pepe, A; D'Amico, G; Morabito, A; Gluud, C | |
| 1-gen-2013 | Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death | VITRANO, Angela + | 01 - Contributo in rivista::1.01 Articolo in rivista | Maggio, A; Vitrano, A; Calvaruso, G; Barone, R; Rigano, P; Mancuso, L; Cuccia, L; Capra, M; Pitrolo, L; Prossomariti, L; Filosa, A; Caruso, V; Gerardi, C; Campisi, S; Cianciulli, P; Elefteriou, A; Angastiniotis, M; Hamzac, H; Telfer, P; Walkerc, JM; Phrommintikul, A; Chattipakorn, N | |
| 1-gen-2015 | The Challenge of Using CB-HSCs As Source for Gene Therapy: Lentiviral Vector Transduction, Phenotypic Characterization and Global Gene Expression Profile of Ex-Vivo Expanded CB CD34+ Cells | BAIAMONTE, ElenaCONTINO, FlaviaCORONNELLO, ClaudiaVITRANO, AngelaFEO, Salvatore + | 10 - Proceedings::Proceedings | Rosalia Di Stefano*, 1.; Baiamonte, E.; Iacono, M.; Spina, B.; Contino, F.; Coronnello, C.; Sacco, M.; Maggio, R.; Vitrano, A.; Feo, S.; Maggio, A.; Acuto, A. |